Selective trafficking of light chain-conjugated nanoparticles to the kidney and renal cell carcinoma-Reference-Cited by-同舟云学术

Selective trafficking of light chain-conjugated nanoparticles to the kidney and renal cell carcinoma

Published:2020-12 Issue: Volume:35 Page:100990
ISSN:1748-0132
Container-title:Nano Today
language:en
Short-container-title:Nano Today

Author:

Ordikhani Farideh,Kasinath Vivek,Uehara Mayuko,Akbarzadeh Aram,A Yilmam Osman,Dai Li,Aksu Hamza,Jung Sungwook,Jiang Liwei,Li Xiaofei,Zhao Jing,Bahmani Baharak,Ichimura Takaharu,Fiorina Paolo,Annabi Nasim,Abdi Reza

Funder

National Institutes of Health

Dialysis Clinics

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Bioengineering,Biotechnology

Reference50 articles.

1. Impact of Nanotechnology on Drug Delivery

2. Receptor-Mediated Endocytosis in the Proximal Tubule

3. Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

4. Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data

5. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted nanomedicine modulating intercellular communications to arrest renal cell carcinoma progression;Journal of Drug Delivery Science and Technology;2024-09

2. Physiological principles underlying the kidney targeting of renal nanomedicines;Nature Reviews Nephrology;2024-02-26

3. Rational nanoparticle design: Optimization using insights from experiments and mathematical models;Journal of Controlled Release;2023-08

4. Cell and gene therapy for kidney disease;Nature Reviews Nephrology;2023-03-27

5. Epigenetic Silencing of LRP2 Is Associated with Dedifferentiation and Poor Survival in Multiple Solid Tumor Types;Cancers;2023-03-17